Zemirciclib clinical trials
Also written AZD4573.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How each study uses zemirciclib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Protein Kinase Inhibitors source
Studies
Open first, then newest update. How each study uses zemirciclib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- AZD4573 in Novel Combinations With Anti-cancer Agents in Patients With Advanced Blood CancerCompletedPhase 1/2AstraZenecaNCT04630756Written as AZD4573
- AZD4573 as Monotherapy or in Combinations With Anti-cancer Agents in Patients With r/r PTCL or r/r cHLCompletedPhase 2AstraZenecaNCT05140382Written as AZD4573
- Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesCompletedPhase 1AstraZenecaNCT03263637Written as AZD4573
Codes
What other systems call zemirciclib · ClinicalTrials.gg INT016419
- UNII (FDA) E5XSP3X68BZEMIRCICLIBOne source FDA
- NCI Thesaurus C153377ZemirciclibOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | E5XSP3X68B | ZEMIRCICLIB | One source FDA |
| NCI Thesaurus | C153377 | Zemirciclib | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.